Michael T. McMahon

johns hopkins university

H指数:53

被引数:8,804

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Correction to “Cell-Penetrating and Enzyme-Responsive Peptides for Targeted Cancer Therapy: Role of Arginine Residue Length on Cell Penetration and In Vivo Systemic Toxicity”

对“用于靶向癌症治疗的细胞穿透和酶响应肽：精氨酸残基长度对细胞穿透和在体系统性毒性的影响”的更正

ACS Applied Materials & Interfaces

IF0

2026-05-130

PRE

Non-Invasive Tracking of rAAV-Mediated Gene Expression in the Liver through a Genetically Encoded MRI Reporter Gene

通过遗传编码的MRI报告基因对肝脏中rAAV介导的基因表达进行无创跟踪

Molecular Therapy

IF12

2025-11-120

PRE

Biocatalytic Construction of a Chemical Exchange Saturation Transfer Magnetic Resonance Imaging Nucleoside Probe: Synthesis and Evaluation of 5-Methyl-5,6-Dihydrothymidine

生物催化构建化学交换饱和转移磁共振成像核苷探针：5-甲基-5,6-二氢胸腺嘧啶的合成与评价

ADVANCED SYNTHESIS & CATALYSIS

IF4

2025-11-010

OAAI

Optimization of CEST MRI Reporter Protein Design Using Cation-Pi Networks

利用阳离子-π相互作用网络优化CEST MRI报告蛋白设计

Chemistry – A European Journal

IF0

2025-09-100

OAAI

Glucose stimulated CEST MRI pHe mapping for improved differentiation of tumors with altered hypoxia inducible factor 1alpha expression

葡萄糖刺激的CEST MRI pHe映射用于改善肿瘤中缺氧诱导因子1α表达变化的鉴别

Scientific Reports

IF3.9

2025-08-090

OAAI

MRI detects tubulointerstitial changes in mouse models of radiation-induced nephropathy

MAGNETIC RESONANCE IN MEDICINE

IF3

2025-01-230

PRE

The proton resonance enhancement for CEST imaging and shift exchange (PRECISE) family of RF pulse shapes for CEST MRI

MAGNETIC RESONANCE IN MEDICINE

IF3

2025-01-200

Intramolecular Hydrogen Bonding Based CEST MRI Contrast Agents As an Emerging Design Strategy: A Mini-Review

ACS OMEGA

IF4.3

2024-06-171

OAAI

Cell-Penetrating and Enzyme-Responsive Peptides for Targeted Cancer Therapy: Role of Arginine Residue Length on Cell Penetration and In Vivo Systemic Toxicity

用于靶向癌症治疗的细胞穿透和酶响应肽: 精氨酸残基长度对细胞穿透和体内全身毒性的作用

ACS APPLIED MATERIALS & INTERFACES

IF8.2

2024-02-225

A Smart Intracellular Self-Assembling Bioorthogonal Raman Active Nanoprobe for Targeted Tumor Imaging

用于靶向肿瘤成像的智能细胞内自组装生物正交拉曼活性纳米探针

ADVANCED SCIENCE

IF14.1

2023-09-156

OAAI

PET/MRI and Bioluminescent Imaging Identify Hypoxia as a Cause of Programmed Cell Death Ligand 1 Image Heterogeneity

RADIOLOGY-IMAGING CANCER

IF6.3

2023-07-013

Acyl Hydrazides and Acyl Hydrazones as High-Performance Chemical Exchange Saturation Transfer MRI Contrast Agents

PHARMACEUTICALS

IF4.8

2023-04-233

OAAI

A Genetic Programming Approach to Engineering MRI Reporter Genes

ACS SYNTHETIC BIOLOGY

IF3.9

2023-03-2211

OAAI

Mapping light distribution in the brain via MRI

NATURE BIOMEDICAL ENGINEERING

IF26.6

2022-12-220

Noninvasive assessment of renal dynamics and pH in a unilateral ureter obstruction model using DCE MR-CEST urography

MAGNETIC RESONANCE IN MEDICINE

IF3

2022-09-118

Quantitative cerebrovascular reactivity MRI in mice using acetazolamide challenge

MAGNETIC RESONANCE IN MEDICINE

IF3

2022-06-175

Unlabeled aspirin as an activatable theranostic MRI agent for breast cancer

THERANOSTICS

IF13.3

2022-01-015

OAAI

Redesigned reporter gene for improved proton exchange-based molecular MRI contrast

SCIENTIFIC REPORTS

IF3.9

2020-11-2615

OAAI

Efficient temperature-feedback liposome for 19F MRI signal enhancement

CHEMICAL COMMUNICATIONS

IF4.2

2020-01-017

PREAI

Furin-mediated intracellular self-assembly of olsalazine nanoparticles for enhanced magnetic resonance imaging and tumour therapy

弗林蛋白酶介导的奥沙拉秦纳米粒的细胞内自组装用于增强磁共振成像和肿瘤治疗

NATURE MATERIALS

IF38.5

2019-10-21180

OAAI

Michael T. McMahon

个人简介

教育背景

工作经历

荣誉奖项

研究方向